KetoSwiss welcomes Daniel Lustenberger as Financial, Business & Strategy Advisor.
A huge step towards the product protection, we will keep you posted.
The KetoSwiss team is enriched by Sebastian, an expert in business development and financial management, who joins KetoSwiss AG as Chief Operating Officer. Welcome!
KetoSwiss raised CHF 0.5 million in a first seed funding round.
Dr. Egle B. Thomas joins KetoSwiss AG as Business & Strategy Advisor. Welcome!
Looking back at 4 years of development, KetoSwiss AG has finalised its product. In a next step, clinical trials will be conducted - we keep you posted.
In addition to migraine, KetoSwiss will clinical test the efficacy of its lead product in Alzheimer's Disease with the first randomised controlled trial starting in summer 2019.
KetoSwiss achieved 5th place at the Swiss Innovation Challenge.
KetoSwiss is taking part in the Swiss Innovation Challenge and made it to the second round - we keep you posted.
The first PK trial on healthy subjects has been completed, the second is starting soon.